We first determined the balance between CD1c+CD14− cells and CD1c+CD14+ cells in peripheral blood of early-stage NSCLC and stage III and IV melanoma patients by flow cytometry and compared this with healthy donors (HDs). This evidence concerns the gene CD14 and non-small cell lung carcinoma.